The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
91640526 9164052 6 F 200602 20160630 20130314 20160701 PER US-009507513-1303USA006754 MERCK 0.00 M Y 93.70000 KG 20160701 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
91640526 9164052 1 PS PROPECIA FINASTERIDE 1 Oral 1 MG, QD 20788 1 MG FILM-COATED TABLET QD
91640526 9164052 2 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 Oral UNK U 0
91640526 9164052 3 C LAMICTAL LAMOTRIGINE 1 Oral 200 MG, QD U 0 200 MG TABLET QD
91640526 9164052 4 C LAMICTAL LAMOTRIGINE 1 Oral UNK U 0 TABLET
91640526 9164052 5 C CELEXA CITALOPRAM HYDROBROMIDE 1 Oral UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
91640526 9164052 1 Androgenetic alopecia
91640526 9164052 2 Bipolar disorder
91640526 9164052 3 Bipolar disorder
91640526 9164052 5 Bipolar disorder

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
91640526 9164052 Asthma
91640526 9164052 Breast mass
91640526 9164052 Chest pain
91640526 9164052 Chronic spontaneous urticaria
91640526 9164052 Cognitive disorder
91640526 9164052 Erectile dysfunction
91640526 9164052 Fall
91640526 9164052 Food allergy
91640526 9164052 Gait disturbance
91640526 9164052 Gynaecomastia
91640526 9164052 Lip swelling
91640526 9164052 Loss of libido
91640526 9164052 Migraine
91640526 9164052 Peripheral swelling
91640526 9164052 Sexual dysfunction
91640526 9164052 Swollen tongue
91640526 9164052 Terminal dribbling
91640526 9164052 Testicular pain
91640526 9164052 Urine flow decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
91640526 9164052 1 20050314 20070830 0
91640526 9164052 2 2003 20070830 0
91640526 9164052 3 2004 0
91640526 9164052 4 2002 0
91640526 9164052 5 2002 0